President and CEO Saccomano Nicholas A sold $378 worth of shares (86 units at $4.40), decreasing direct ownership by 0.76% to 11,247 units (SEC Form 4) (for tax liability)
4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
Live Feed
Delayed 3mPress · Analyst · Insider · Buys · SEC · Financials
Signed out · 3-min delay · Sign up for real-time
- Chief Development Officer Mcbee Brannin sold $55,633 worth of shares (500 units at $111.27) as part of a pre-agreed trading plan (SEC Form 4)
4 - CoreWeave, Inc. (0001769628) (Issuer)
- Chief Financial Officer Leverone Jason A. sold $1,332 worth of shares (303 units at $4.40), decreasing direct ownership by 2% to 18,802 units (SEC Form 4) (for tax liability)
4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
- EVP, Product Management Kleinerman Christian covered exercise/tax liability with 2,652 shares and sold $598,767 worth of shares (2,621 units at $228.45) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 400,379 units (SEC Form 4) (withholding obligation)
4 - Snowflake Inc. (0001640147) (Issuer)
- SEC Form 4 filed by Chief Bus. Development Officer Cao Sean Wuxiong
4 - NovaBridge Biosciences (0001778016) (Issuer)
- Large owner Orbimed Advisors Llc sold $39,014,046 worth of shares (860,123 units at $45.36) (SEC Form 4)
4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Enliven Therapeutics Inc.
SCHEDULE 13D/A - Enliven Therapeutics, Inc. (0001672619) (Subject)
- Western Union and Intermex Provide an Update on Pending Acquisition of Intermex
DENVER and MIAMI, June 24, 2026 (GLOBE NEWSWIRE) -- The Western Union Company ("Western Union") (NYSE:WU) and International Money Express, Inc. ("Intermex") (NASDAQ:IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to
- WM Technology, Inc. Announced Adjournment of 2026 Annual Meeting of Stockholders
WM Technology, Inc. ("WM Technology" or the "Company") (OTC:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced that the Company’s 2026 Annual Meeting of Stockholders (the "Annual Meeting") held in virtual form on Wednesday, June 24, 2026 at 10:00 a.m. Pacific Time, was convened and adjourned until Thursday July 16, 2026 at 10:00 a.m. Pacific Time without any business being conducted. The Company adjourned the Annual Meeting for the purpose of allowing additional time for stockholders to vote on the proposal to amend the Company’s Certificate of Incorporation to declassify the Board of Directors of the Company (the "Board") and to provide
- Western Union and Intermex Provide an Update on Pending Acquisition of Intermex
The Western Union Company ("Western Union") (NYSE:WU) and International Money Express, Inc. ("Intermex") (NASDAQ:IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to obtain the final regulatory approval. Western Union